Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Am J Trop Med Hyg ; 28(4): 649-52, 1979 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-111570

RESUMEN

First instar Dipetalogaster maximus proved as effective as third instar Triatoma infestans in detecting circulating Trypanosoma cruzi in patients with chronic infections examined in a routine xenodiagnostic laboratory. Since rearing costs are diminished, D. maximus has now replaced T. infestans as the xenodiagnostic agent in our laboratory. However, further work is needed to define the optimal conditions necessary when using this species in xenodiagnosis.


Asunto(s)
Enfermedad de Chagas/diagnóstico , Triatominae/parasitología , Animales , Sangre/parasitología , Enfermedad de Chagas/parasitología , Humanos , Trypanosoma cruzi
2.
Am J Trop Med Hyg ; 59(4): 543-5, 1998 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9790427

RESUMEN

We report the long-term clinical follow-up of two patients with unresponsive mucosal leishmaniasis due to Leishmania (Viannia) braziliensis from the Três Braços area in Bahia State, Brazil. Both were agricultural male workers with extensive upper respiratory mucosal involvement that was not cured with conventional and experimental therapy.


Asunto(s)
Leishmania braziliensis , Leishmaniasis Mucocutánea/tratamiento farmacológico , Adulto , Animales , Humanos , Masculino
3.
Trans R Soc Trop Med Hyg ; 74(4): 508-14, 1980.
Artículo en Inglés | MEDLINE | ID: mdl-7445048

RESUMEN

Biopsies of skin and mucosal lesions were made on 60 well documented Brazilian patients with untreated cutaneous or mucocutaneous leishmaniasis, whose response to treatment was subsequently evaluated in 38 cases. The biopsies were examined with a view to classification after correlation with clinical and immunological findings. Although there was no simple or unified spectrum, five histological groups were defined and found to have some clinico-prognostic significance. In two groups the cases were all cutaneous with a relatively good prognosis. In another two groups they were evolving as mucocutaneous with a poor prognosis. The fifth group showed mixed characteristics with a tendency to relapse. There was no strong correlation with serum antibodies or Montenegro skin test, which were usually positive, or with parasite load, which was always low. The tissue response was distinguished from that in oriental sore by the degree of connective tissue involvement in all groups. It was the primary response in two groups, and subsidiary to a mono-nuclear response in the others. It suggested damage due to extra-cellular parasites or immune complexes. It did not correlate with the distinction between cutaneous and mucocutaneous disease. The single, most favourable, prognostic feature in either the cellular or connective tissue component was necrosis with a reactive response.


Asunto(s)
Leishmaniasis Mucocutánea/clasificación , Anticuerpos/análisis , Brasil , Humanos , Leishmaniasis/clasificación , Leishmaniasis/inmunología , Leishmaniasis/patología , Leishmaniasis Mucocutánea/inmunología , Leishmaniasis Mucocutánea/patología , Membrana Mucosa/patología , Piel/patología
4.
Trans R Soc Trop Med Hyg ; 75(3): 335-7, 1981.
Artículo en Inglés | MEDLINE | ID: mdl-7324099

RESUMEN

At a dosage level of 8 to 10 mg/kg body-weight daily for 120 days nifurtimox was associated with clinical healing of cutaneous leishmaniasis in five of eight patients. At a dosage level of 20 mg/kg body-weight daily for 10 days in six of 10 patients the skin ulcer healed. Results and the reasons why both schemes are impracticable are briefly discussed.


Asunto(s)
Leishmaniasis/tratamiento farmacológico , Nifurtimox/uso terapéutico , Nitrofuranos/uso terapéutico , Adolescente , Adulto , Anciano , Niño , Esquema de Medicación , Femenino , Humanos , Leishmaniasis Mucocutánea/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Nifurtimox/administración & dosificación , Nifurtimox/efectos adversos
5.
Trans R Soc Trop Med Hyg ; 73(4): 391-4, 1979.
Artículo en Inglés | MEDLINE | ID: mdl-555065

RESUMEN

A trial of Nifurtimox (Lampit) in 26 patients with mucocutaneous leishmaniasis is reported. 13 patients with cutaneous lesions and 13 patients with mucosal disease were treated with a daily oral divided dose of 10 mg/kg body-weight for 30 days. 46% of the cutaneous cases and only 15% of the mucosal cases apparently responded to this regimen during at least one year of follow up. The difficulties of assessing cure in this disease are briefly discussed. We consider that Nifurtimox remains an investigational drug. While possibly exhibiting some anti-leishmanial activity it cannot be recommended for routine use in either form of the disease.


Asunto(s)
Leishmaniasis Mucocutánea/tratamiento farmacológico , Nifurtimox/uso terapéutico , Nitrofuranos/uso terapéutico , Adolescente , Adulto , Anciano , Niño , Estudios de Seguimiento , Humanos , Leishmaniasis Mucocutánea/diagnóstico , Persona de Mediana Edad , Mucosa Nasal , Nifurtimox/efectos adversos
6.
Trans R Soc Trop Med Hyg ; 73(5): 524-7, 1979.
Artículo en Inglés | MEDLINE | ID: mdl-119338

RESUMEN

In patients serologically positive for Trypanosoma cruzi infection the three bug species/instar combinations used in xenodiagnosis showed third-instar Dipetalogaster maximus to be more efficient in detecting circulating trypanosomes than the first instar of the same species which, in turn, is more sensitive than third-instar Triatoma infestans. The sensitivity of the pool technique of faecal examination compared with individual dissection was investigated. Four pool examinations (the product of 20 bugs) were equivalent to 10 individual bug dissections. Because of the ease of providing large numbers of bugs for mass xenodiagnosis, first-instar D. maximus has replaced third-instar T. infestans in our routine work. The value of third-instar D. maximus as a xenodiagnostic agent needs further investigation.


Asunto(s)
Enfermedad de Chagas/diagnóstico , Triatominae/parasitología , Interacciones Huésped-Parásitos , Humanos , Larva , Métodos , Trypanosoma cruzi/fisiología
7.
Trans R Soc Trop Med Hyg ; 84(3): 367-70, 1990.
Artículo en Inglés | MEDLINE | ID: mdl-2260171

RESUMEN

Seventy-nine patients with cutaneous (62) or mucosal (17) infection with Leishmania (Viannia) braziliensis in Três Braços, Bahia, Brazil, were followed for at least 4 years after initiating treatment with antimony. Cutaneous relapses occurred in 6/62 (10%), mucosal relapse after cutaneous infection in 2/62 (3%), and mucosal relapse after mucosal disease in 2/17 (17%). It is concluded that relapse (cutaneous and mucosal) is rare after adequate antimony therapy and that no definite prediction of relapse (clinical, serological or by skin reaction) is possible.


Asunto(s)
Antiprotozoarios/uso terapéutico , Leishmania braziliensis , Leishmaniasis/tratamiento farmacológico , Meglumina/uso terapéutico , Compuestos Organometálicos/uso terapéutico , Adolescente , Adulto , Anciano , Animales , Antimonio/uso terapéutico , Niño , Femenino , Humanos , Masculino , Antimoniato de Meglumina , Recurrencia , Úlcera Cutánea/tratamiento farmacológico , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA